A patient comes with a history of asthma and sinusitis. On looking into his medical records, you notice this has been attributed to Samter's triad. Which drug should be avoided in this patient?

Correct Answer: C. Aspirin

Samter's triad (also called aspirin-exacerbated respiratory disease or AERD) is a clinical syndrome characterized by the classic triad of asthma, chronic rhinosinusitis with nasal polyps, and reactions to NSAIDs (particularly aspirin). The pathophysiology involves abnormal arachidonic acid metabolism: NSAIDs inhibit COX-1, shunting arachidonic acid toward the 5-lipoxygenase pathway, leading to excessive leukotriene production. This causes bronchoconstriction, urticaria, angioedema, and anaphylaxis within minutes to hours of NSAID ingestion. Aspirin is the prototypical NSAID that must be strictly avoided in Samter's triad patients. Other NSAIDs (ibuprofen, naproxen, indomethacin) are equally contraindicated. Acetaminophen and selective COX-2 inhibitors (celecoxib) are safer alternatives. The diagnosis is clinical (history of asthma + chronic sinusitis + nasal polyps + NSAID reaction), though aspirin challenge testing can confirm it in specialized centers. Indian guidelines emphasize patient education and avoidance of all NSAIDs in suspected AERD cases, with consideration of leukotriene receptor antagonists (montelukast) for symptom control.

Why the other options are wrong

A. Co-amoxiclav — Co-amoxiclav is a beta-lactam antibiotic combination (amoxicillin + clavulanic acid) used for respiratory and sinus infections. It does not inhibit COX-1 and does not trigger leukotriene-mediated reactions. While any antibiotic can cause hypersensitivity in susceptible individuals, co-amoxiclav is not contraindicated in Samter's triad. This is an NBE trap: students may confuse drug allergy with AERD pathophysiology. B. Cotrimoxazole — Cotrimoxazole (trimethoprim-sulfamethoxazole) is a sulfonamide antibiotic used for respiratory infections and sinusitis. It has no COX-inhibitory activity and does not trigger arachidonic acid shunting. Although sulfonamides can cause Stevens-Johnson syndrome or other hypersensitivity reactions in some patients, they are not specifically contraindicated in AERD. This option exploits confusion between drug allergy and NSAID-induced AERD. D. Chloramphenicol — Chloramphenicol is a broad-spectrum antibiotic that inhibits bacterial protein synthesis. It has no role in COX-1 inhibition or leukotriene metabolism. Although chloramphenicol carries risks of bone marrow suppression and aplastic anemia, these are unrelated to Samter's triad pathophysiology. This option is a distractor testing whether students confuse antibiotic toxicity with AERD-specific contraindications.

High-Yield Facts

Mnemonics

SAMTER = Sinusitis, Asthma, Medication (NSAID) Triad, Exacerbation, Reactions Helps recall the three components and the NSAID trigger. Use when asked about AERD or aspirin-exacerbated disease. COX-1 Block → Leukotrienes ↑ = AERD NSAIDs block COX-1 → arachidonic acid diverted to 5-LOX → leukotriene surge → asthma + urticaria. Mnemonic for the biochemical mechanism.

NBE Trap

NBE pairs Samter's triad with antibiotic options (co-amoxiclav, cotrimoxazole, chloramphenicol) to lure students into confusing drug allergy or antibiotic toxicity with NSAID-induced AERD. The key discriminator is that AERD is triggered by COX-1 inhibition, not by antibiotic mechanisms.

Clinical Pearl

In Indian outpatient practice, many patients with chronic sinusitis and asthma self-medicate with aspirin or ibuprofen for headache or fever, triggering life-threatening AERD reactions. Screening for this triad during initial asthma assessment and patient counseling on NSAID avoidance (including hidden NSAIDs in combination analgesics) is critical for safety.

_Reference: Harrison Ch. 256 (Asthma); Robbins Ch. 15 (Respiratory pathology); KD Tripathi Ch. 7 (NSAIDs and COX inhibition)_